Basic HTML Version
97
SCIENTIFIC REPORT 2012
Title:
Quasi-experimental study to assess the efficiency of a proactive intervention in relation to
the psychosocial needs of the cancer patient and their relatives at the time of the
diagnosis.
District Attorney:
AECC Scholarship.
Principal Investigator:
Miquel Àngel I followed Palmer.
Title:
Phase IIIB study, comparative, randomized, parallel group, multicenter, for
to investigate the efficacy of subcutaneous rituximab (SC) versus intravenous rituximab, both in
combination with CHOP (R-CHOP), in patients with diffuse large B-cell lymphoma
(LDCBG) CD20 positive, not previously treated.
District Attorney:
F. Hoffmann-La Roche Ltd.
Principal Investigator:
Joan Alfonso Soler Campos.
Title:
Post-authorization observational study to assess the response of renal function to
treatment of patients with multiple myeloma in relapse and with creatinine clearance
<50 ml / min / 1,73 m2 (CrCl <50 ml / min / 1,73 m2) (MIR50 study).
District Attorney:
CELGENE.
Principal Investigator:
Joan Alfonso Soler Campos.
Publications
Am J Surg Pathol
. 2012 Feb;36(2):296-304.
Primary bone marrow lymphoma: an
uncommon extranodal presentation of aggressive non-hodgkin lymphomas
. Martinez A,
Ponzoni M, Agostinelli C, Hebeda KM, Matutes E, Peccatori J, Campidelli C, Espinet B, Perea
G, Acevedo A, Mehrjardi AZ, Martinez-Bernal M, Gelemur M, Zucca E, Pileri S, Campo E,
Lopez-Guillermo A, Rozman M; International Extranodal Lymphoma Study Group.
Ann oncol
. 2012 Jan;23(1):104-11.
Effect of protocol-related variables and women's
characteristics on the cumulative false-positive risk in breast cancer screening
. Roman
R, Room M, Rooms D, Ascunce N, Zubizarreta R, Castells X; Cumulative False Positive Risk
Group (Baré M.).
Ann oncol
. 2012 Jul;23(7):1919-25.
Phase II open-label study of erlotinib in combination
with gemcitabine in unresectable and / or metastatic adenocarcinoma of the pancreas:
relationship between skin rash and survival (Pantar study)
. Aranda E, Manzano JL, Rivera
F, Galán M, Valladares-Ayerbes M, Pericay C, Safont MJ, Mendez MJ, Irigoyen A, Arrivi A,
Sastre J, Díaz-Rubio E.
Anticancer Drugs
. 2012 Jun; 23 Suppl: S13-4.
Intervention in gastrointestinal stromal tumor
with a high risk of malignancy and associated with thalassemia minor
. Pericay Pajaume
C, Saigí E.